Revenue Growth
 2008 | 2007 | 2006 | 2005 | | ||||
2005 | Q1 | Q2 | Q3 | Q4 | Full Year |
GAAP Revenue Growth | 12.46% | 9.0% | 13.7% | 13.7% | 12.2% |
Revenue Growth Excluding Changes in Foreign Exchange Rates | 9.4% | 6.51% | 13.1% | 18.8% | 11.9% |
Total Millipore Organic Revenue Growth* | 9.4% | 6.51% | 10.6% | 14.3% | 10.2% |
Bioprocess Division Organic Revenue Growth* | 13.6% | 8.6% | 11.4% | 16.49% | 12.5% |
Bioscience Division Organic Revenue Growth* | 3.6% | 3.49% | 9.49% | 11.3% | 6.9% |
| | ||||
IR Contact
Contact for shareholders, potential investors and financial media.
Joshua S. Young
Director, Investor Relations
Tel: 978-715-1527
Joshua_Young@millipore.com
Millipore Contact InformationIR Services
Sign up for company alerts and download reports.
FAQs
Email Subscriptions
Download Documents
Order ReportsSafe Harbor Statement
The information on the Millipore investor relations website, as well as in future oral and written statements by management of Millipore Corporation that are forward-looking statements, are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements.
» More